Viewing Study NCT04485559


Ignite Creation Date: 2025-12-24 @ 2:50 PM
Ignite Modification Date: 2026-01-28 @ 1:38 PM
Study NCT ID: NCT04485559
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2020-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent World Health Organization (WHO) Grade II Glioma View
None Low-grade Glioma View
None High Grade Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mitogen-activated protein kinase (MAPK) View
None phosphatidylinositol 3-kinase (PI3K) View
None MAPK View
None PI3K View